1. Current and Future Perspectives on Migraine Prevention Therapy

2. Program Overview

3. Characteristics of Migraine

4. Current Migraine Prevention Treatment

5. Adherence to Migraine Prevention Treatment

6. Medication Overuse Headache: EFNS Headache Panel Guideline

7. CGRP Elevation in Migraine Attacks

8. Release of Perivascular Neuropeptides During Acute Primary Headache Attacks

9. CGRP Receptor Mechanisms

10. Acute Treatment With CGRP Receptor Blockers and Migraine Headache Relief

11. Effect of CGRP mAbs on Episodic Migraine: Phase 2 Trials with Different Populations and Regimens

12. 50% Responder Rate in Phase 2 Trial of AMG334

13. Monoclonal Antibodies Targeting the CGRP Pathway

14. Findings for CGRP in SAH

15. Adverse Events With CGRP mAbs in Phase 2 Studies

16. CGRP, the Trigeminal Ganglion, and the Blood Brain Barrier

17. Other Areas for Research

18. Concluding Remarks

19. Abbreviations